FDG PET/CT in Detection of Metastatic Involvement of Heart and Treatment Monitoring in Non-Hodgkin′s Lymphoma

Kanhaiyalal Agrawal; Bhagwant Mittal; Kuruva Manohar; Raghava Kashyap; Anish Bhattacharya; Subhash Varma

doi:10.4103/1450-1147.98746

World Journal of Nuclear Medicine, Table of Contents

CC BY-NC-ND 4.0 · World J Nucl Med 2012; 11(01): 33-34
DOI: 10.4103/1450-1147.98746

Review article

FDG PET/CT in Detection of Metastatic Involvement of Heart and Treatment Monitoring in Non-Hodgkin′s Lymphoma

Kanhaiyalal Agrawal

Department of Nuclear Medicine and PET, Postgraduate Institute of Medical Education and Research, Chandigarh, India

,

Bhagwant Mittal

Department of Nuclear Medicine and PET, Postgraduate Institute of Medical Education and Research, Chandigarh, India

,

Kuruva Manohar

Department of Nuclear Medicine and PET, Postgraduate Institute of Medical Education and Research, Chandigarh, India

,

Raghava Kashyap

Department of Nuclear Medicine and PET, Postgraduate Institute of Medical Education and Research, Chandigarh, India

,

Anish Bhattacharya

Department of Nuclear Medicine and PET, Postgraduate Institute of Medical Education and Research, Chandigarh, India

,

Subhash Varma

¹Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India

› Author Affiliations

Abstract

PDF Download

Cardiac metastasis occurs in up to a quarter of patients with metastatic cancer and is seen most commonly in melanoma and lymphoma. Metastatic involvement of the heart and pericardium may go unrecognized until autopsy. We describe a patient of non-Hodgkin′s lymphoma detected to have involvement of right atrium on F-18 FDG PET/CT and monitoring of response to chemotherapy.

Keywords

Cardiac metastases - FDG PET/CT - lymphoma - response evaluation

PDF (495 kb)